Results 191 to 200 of about 148,376 (307)

Complete resolution of gastric amyloidosis after autologous stem cell transplantation [PDF]

open access: bronze, 2008
D. Cherian   +4 more
openalex   +1 more source

Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis

open access: yesJournal of the American College of Cardiology, 2020
C. Nitsche   +22 more
semanticscholar   +1 more source

Larynx Amyloidosis [PDF]

open access: yesEar, Nose & Throat Journal, 2003
Lee M, Akst, Lester D, Thompson
openaire   +2 more sources

Synaptic Vesicle Glycoprotein 2A Suppresses Amyloidogenesis Beyond Its Synaptic Role: A Novel Mechanism Disrupting BACE1 Binding and Altering APP Localization

open access: yesAging Cell, Volume 25, Issue 2, February 2026.
Synaptic vesicle glycoprotein 2A, the newly identified APP‐binding protein, reduces amyloid‐β plaque deposition in Alzheimer's disease by suppressing the amyloidogenic pathway through inhibition of BACE1‐APP interaction and alteration of APP endosomal‐lysosomal localization.
Xiaoling Wang   +11 more
wiley   +1 more source

Best therapy for primary amyloidosis, a not-yet-solved question [PDF]

open access: bronze, 2004
Arnaud Jaccard   +3 more
openalex   +1 more source

The incidence of serious complications after selective laser trabeculoplasty

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page 106-113, February 2026.
Abstract Purpose To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT). Methods All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018.
Eeva S. Ojanen   +2 more
wiley   +1 more source

Silent progression: cardiac amyloidosis unmasking IgG lambda myeloma in an elderly patient. [PDF]

open access: yesEgypt Heart J
Touiti S   +5 more
europepmc   +1 more source

Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients

open access: yesClinical Transplantation, Volume 40, Issue 2, February 2026.
ABSTRACT Background and Aims Post liver transplantation (LT) inflammation and fibrosis are clinical challenges that may affect long‐term outcomes. We aimed to investigate sCD163 as a biomarker of liver fibrosis in LT recipients and compare it with the Fibrosis 4 (FIB‐4) score and FibroScan.
Emilie Høegholm Ernst Lauridsen   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy